Senores Pharmaceuticals Limited has informed the Exchange regarding copy of Newspaper Publication for extracts of Unaudited Standalone and Consolidated Financial Results of the Company for quarter and nine months ended December 31, 2025.
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The company has informed the stock exchange that it has published newspaper extracts of its unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, in compliance with listing regulations. This is a routine regulatory disclosure confirming public dissemination of the quarterly results, which were already filed with the exchange in a separate earlier announcement. The filing itself does not contain fresh financial figures—only the notice of publication.
This is a standard compliance disclosure with no new financial information. Investors seeking Q3 performance numbers should refer to the original results announcement filed earlier with the exchange for the actual revenue, profit, and growth metrics.